BM
RCKT icon

Bridger Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bridger Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,247,366
Closed -$18.7M – 33
2019
Q2 		$18.7M Sell
1,247,366
-281,666
-18% -$4.92M 1.47% 24
2019
Q1 		$26.8M Sell
1,529,032
-223,870
-13% -$3.53M 2.12% 23
2018
Q4 		$26M Hold
1,752,902
– – 2.17% 21
2018
Q3 		$43.2M Hold
1,752,902
– – 2.5% 19
2018
Q2 		$34.4M Buy
1,752,902
+174,333
+11% +$3.3M 1.86% 26
2018
Q1 		$29.6M Buy
+1,578,569
New +$25.7M 1.8% 25

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bridger Management's RCKT Position: Q3 2019 in Review

Bridger Management sold out of Rocket Pharmaceuticals (RCKT) in Q3 2019, closing a stake of 1,247,366 shares — an estimated $18.7M sold.

Bridger Management first reported a position in RCKT in Q1 2018 and held it in 6 quarters. The position peaked at $43.2M in Q3 2018. 92 funds tracked by Wall St. Rank hold RCKT as of Q3 2019.

  • Bridger Management reported no remaining Rocket Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bridger Management sold 1,247,366 Rocket Pharmaceuticals shares in Q3 2019, an estimated $18.7M.
  • Bridger Management first reported a position in Rocket Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Bridger Management's Rocket Pharmaceuticals position peaked at $43.2M in Q3 2018.
  • 92 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2019.

Based on Bridger Management's 13F filing for Q3 2019, filed 14 Nov 2019.